Scitus Pharma Services Profile
Key Indicators
- Authorised Capital ₹ 16.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 14.52 Cr
as on 15-11-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 24.02%
(FY 2023)
- Profit 19.76%
(FY 2023)
- Ebitda 247.70%
(FY 2023)
- Net Worth 16.50%
(FY 2023)
- Total Assets 18.27%
(FY 2023)
About Scitus Pharma Services
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 16.00 Cr and a paid-up capital of Rs 14.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Scitus Pharma Services Private Limited India is Neema Pandey as COMPANY SECRETARY. Shanmugam Muthusamy, Ayyavu Rajavel, Jayanthy Shanmugam, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999TN2017PTC118805
- Company No.
118805
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Scitus Pharma Services?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neema Pandey | Company Secretary | 01-Oct-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shanmugam Muthusamy  | Director | 26-Sep-2017 | Current |
Ayyavu Rajavel  | Director | 26-Sep-2017 | Current |
| Jayanthy Shanmugam | Director | 08-Jul-2019 | Current |
| Sruthi Shanmugam | Director | 01-Oct-2021 | Current |
| Sankar | Director | 01-Oct-2021 | Current |
Financial Performance of Scitus Pharma Services.
Scitus Pharma Services Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.02% increase. The company also saw a substantial improvement in profitability, with a 19.76% increase in profit. The company's net worth Soared by an impressive increase of 16.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scitus Pharma Services?
In 2023, Scitus Pharma Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saimirra Innopharm Private LimitedActive 24 years 9 monthsShanmugam Muthusamy and Ayyavu Rajavel are mutual person
Nuray Chemicals Private LimitedActive 12 years 6 monthsShanmugam Muthusamy and Ayyavu Rajavel are mutual person
Annamar Pharma LlpActive 9 years 4 monthsShanmugam Muthusamy and Jayanthy Shanmugam are mutual person
- Esjay Pharma Private LimitedActive 2 years 2 months
Shanmugam Muthusamy and Ayyavu Rajavel are mutual person
- Sthree Pharmaceuticals Private LimitedActive 9 years 4 months
Shanmugam Muthusamy, Ayyavu Rajavel and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Scitus Pharma Services?
Scitus Pharma Services has a workforce of 157 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scitus Pharma Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scitus Pharma Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
